Black Rock Inc. Aim Immuno Tech Inc. Transaction History
Black Rock Inc.
- $4.23 Trillion
- Q1 2024
A detailed history of Black Rock Inc. transactions in Aim Immuno Tech Inc. stock. As of the latest transaction made, Black Rock Inc. holds 698,333 shares of AIM stock, worth $300,283. This represents 0.0% of its overall portfolio holdings.
Number of Shares
698,333
Previous 707,806
1.34%
Holding current value
$300,283
Previous $311,000
5.47%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AIM
# of Institutions
35Shares Held
4.09MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.99MShares$855,1420.0% of portfolio
-
Geode Capital Management, LLC Boston, MA352KShares$151,2120.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny221KShares$94,9470.0% of portfolio
-
State Street Corp Boston, MA173KShares$74,4340.0% of portfolio
-
Verition Fund Management LLC Greenwich, CT171KShares$73,5300.0% of portfolio
About AIM ImmunoTech Inc.
- Ticker AIM
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,049,300
- Market Cap $20.7M
- Description
- AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...